All are described as rare, with real-world data placing serious digestive events in under one percent of users, though the post notes individual risk shifts with baseline health, comorbidities, and interactions with other medications
Like I would rather see you have, you know, more body fat to a point, right
Think of L-carnitine as a support tool that helps optimize how the body uses energy not a replacement for training or nutrition
While various risk factors for enhanced APAP toxicity have emerged in the numerous experimental models of steatosis, including induction of Cyp2E1, reduced phase II metabolism, mitochondrial dysfunction, etc., opposite effects have also been described, suggesting that steatosis may not affect toxicity [180]
p53 regulates lipid metabolism by controlling proteins such as NPC1L1, EPLIN, CEL, and PLTP